Published date: 1 July 2020
Last edited date: 17 July 2020
This notice was replaced on 14 April 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 14 April 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
North East
Value of contract
£1,000,000
Procurement reference
1756
Published date
1 July 2020
Closing date
22 July 2020
Contract start date
17 August 2020
Contract end date
16 August 2024
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
This is an accelerated procedure.
Justification
The COVID-19 outbreak has given rise to an urgent need for the supply of Lipids because of an urgent need to respond and develop a vaccine. This does not give CPI sufficient time to comply with the standard open procedure timescales for this procurement. CPI considers this to be a state of urgency which it has duly substantiated. Accordingly, CPI is using the accelerated time limits permitted under the Public Contract Regulations 2015 (regulation [27(5) for the open procedure) in respect of this procurement.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
In response to the Covid-19 manufacture programme CPI wish to establish a preferred supplier list for the supply of Lipids for both GMP and non-GMP projects. The Tender is split into two Lots. Lot 1 - GMP Qualified Supplier for the provision of Lipids. Lot 2 - Suppliers for the provision of Lipids
About the buyer
Contact name
CPI Procurement
Address
Wilton
REDCAR
TS104RF
England
Telephone
01740 625716
Share this notice